Genzyme Corp. (NASDAQ: GENZ) today reported Q4 sales rose 13% to $1.17 billion, reflecting an approximate negative $39 million impact ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE